SlideShare a Scribd company logo
E D I T O R I A L C O M M E N T A R Y
HIV Infection: Still a Disease for Experts
Joel E. Gallant
Southwest CARE Center, Santa Fe, New Mexico
(See the HIV/AIDS Major Article by O’Neill et al on pages 1871–7.)
Keywords. HIV; AIDS; expertise; primary care.
For decades, human immunodeficiency
virus (HIV) infection was viewed as a dis-
ease that should be managed by experts.
This was based on the multitude of po-
tential complications, the complexity of
antiretroviral drug regimens and their
toxicities, the need for understanding
of drug resistance, and the numerous
interactions between many HIV drugs
and other commonly used medications.
This assumption was supported by data
showing improved outcomes, prolonged
survival, and lower costs when HIV-
infected patients were managed by ex-
perts [1–6].
The term “HIV expert” was never well
defined, because there is no specialty
boardforHIVmedicine. HIVexpertshave
included infectious disease specialists,
family practitioners, internists, pediatri-
cians, as well as nonphysician providers
such as nurse practitioners and physician
assistants. The HIV Medicine Associa-
tion and the American Academy of
HIV Medicine (AAHIVM) have attempt-
ed to define HIV expertise using a combi-
nation of provider experience (patient
volume) and HIV-specific continuing
medical education (CME). The AAHIVM
also requires passing of an open-book
exam for certification as a “practicing
HIV specialist.”
In recent years, the need for HIV ex-
pertise has been questioned. It has been
argued that the earlier studies don’t
apply in an era when we can treat HIV in-
fection with simple, well-tolerated regi-
mens, including several single tablet
combinations. Virologic failure is now
less common, making it less important
to have a thorough understanding of drug
resistance. Many of the recommended
treatment regimens have few drug inter-
actions. At the same time, the Affordable
Care Act (ACA) makes it possible for
most HIV-infected patients to be covered
by private insurance or Medicaid, lessen-
ing the need for reliance on HIV clinics
funded by the Ryan White HIV/AIDS
Program (RWHAP). Those on Medicaid
will increasingly be treated in Federally
Qualified Health Centers (FQHCs), which
may not always have providers with HIV
expertise. These factors have encouraged
many to talk about HIV infection as a
“primary care disease.”
The study by O’Neill and colleagues in
this issue of Clinical Infectious Diseases
[7] suggests that it is premature to reclas-
sify HIV infection as a disease that can be
managed by generalists. The authors
compared outcomes of HIV-infected pa-
tients in New York state who were treated
by low volume providers (LVPs), defined
as clinicians prescribing antiretroviral
therapy (ART) to less than 20 patients,
with those managed by more experienced
providers, caring for at least 20 patients.
They found 368 providers who confirmed
that they were providing HIV care for less
than 20 patients (average 4.3). Of those, 84
submitted the medical records of 320
patients for review. Those records were
compared with records from experienced
providers, randomly sampled from 186
HIVprograms.Performancemeasureswere
based on DHHS (Department of Health
and Human Services) guidelines in place
at the time. Patients of LVPs were less likely
to be virologically suppressed and had
lower scores for all quality of care indica-
tors, including frequency of clinic visits,
viral load and CD4 count monitoring,
and mental health and syphilis screening.
The authors point out that there may be
a selection bias affecting their findings in
that those providers who responded to
the survey and agreed to provide patient re-
cords may have been more confident of the
quality of their care than those who did not,
potentiallyhidingevengreaterdiscrepancies
between LVPs and experienced providers.
It has been argued that 20 patients may
be an unreasonable standard for rural
areas. However, in this study, although
patients living outside the New York met-
ropolitan area were more likely to be
cared for by LVPs, nearly three-quarters
of the LVPs were practicing in the metro-
politan area, where there is no shortage of
HIV experts.
Received 6 August 2015; accepted 11 August 2015; elec-
tronically published 30 September 2015.
Correspondence: Joel E. Gallant, MD, MPH, Southwest
CARE Center, 649 Harkle Rd, Ste E, Santa Fe, New Mexico
(jgallant@southwestcare.org).
Clinical Infectious Diseases®
2015;61(12):1878–9
© The Author 2015. Published by Oxford University Press
on behalf of the Infectious Diseases Society of America. All
rights reserved. For Permissions, please e-mail: journals.
permissions@oup.com.
DOI: 10.1093/cid/civ724
1878 • CID 2015:61 (15 December) • EDITORIAL COMMENTARY
atHINARIPeruAdministrativeAccountonDecember7,2015http://cid.oxfordjournals.org/Downloadedfrom
This is the first study to assess the effect
of provider expertise on quality of care in
a large state or public health jurisdiction,
and it is also the most contemporary. The
data collected were based on antiretrovi-
ral therapy (ART) prescribed in 2009. Al-
though significant improvements have
occurred in the last 6 years, 2009 is still
part of the “modern ART era,” character-
ized by simpler, better tolerated, and less
toxic treatments.
Why the difference? The obvious an-
swer is simply greater experience and
knowledge among providers who treat
more HIV-infected patients. However,
other factors may also play a role. Provid-
ers caring for more HIV-infected patients
may be working in environments with
support services, including behavioral
healthservices,substanceabusetreatment,
case management, and adherence sup-
port: the kind of “wrap-around” services
typically found in Ryan White clinics.
They may also have more access to on-site
HIV education and expert supervision.
Our healthcare environment is rapidly
changing. HIV-infected patients are in-
creasingly likely to be managed by gener-
alists in FQHCs or primary care practices
rather than in Ryan White clinics. The
number of clinicians choosing HIV care
as a profession is shrinking. In such a cli-
mate, how do we maintain high-quality
HIV care, which is critical not only for
the health of patients but also for decreas-
ing HIV transmission and controlling the
epidemic? In urban and suburban areas,
clinics must recognize the importance of
HIV expertise, either by hiring experts or
by supporting HIV training by some of
their providers. This may include atten-
dance at HIV courses or preceptorships
in existing HIV clinics as well ongoing
HIV-specific CME. Co-management by
primary care providers and HIV experts
is underutilized, and is especially impor-
tant in rural areas where there may be no
experts. This can be achieved either by
infrequent visits with an expert, regular
communication between the generalist or
the expert, or through telemedicine, which
must be adequately compensated by third
party payers [8]. Teleconferencing pro-
grams, such as Project ECHO, can be used
to build expertise among primary care pro-
viders and budding HIV experts through
regular lectures and case presentations.
The findings from the O’Neill study
emphasize the critical need for im-
plementation of HIV-specific quality
measures—most importantly viral load
suppression—by public and private in-
surers. They also make a strong argument
for continued funding for the RWHAP.
Although some have argued that the
RWHAP is unnecessary after passage of
the ACA, Ryan White clinics have be-
come centers of excellence for HIV care
and have provided training for HIV pro-
viders over several decades. They offer
support services that may not exist in
other healthcare settings and that have
been critical in keeping HIV-infected pa-
tients retained in care and virologically
suppressed: the key components of treat-
ment-as prevention [9–11]. Attempts
have also been made to solidify and for-
malize the definition of an HIV expert,
including the proposal for a board exam
that would provide “focused practice rec-
ognition” to providers from a variety of
disciplines. However, for such recognition
and certification to have meaning, private
and government insurers would have to
recognize the value of HIV expertise,
making it an indicator of quality care.
Diagnosing HIV infection, enrolling
and retaining patients in care, and sup-
pressing their viral loads on ART are
fundamental to controlling the HIV epi-
demic. HIV care may be easier than it
used to be, but it is still complex. This is
no time to relax our standards and turn
HIV care over to generalists. HIV in-
fection should still be managed—or co-
managed—by experts.
Note
Potential conflict of interest. The author
is the Immediate Past Chair, HIV Medicine
Association.
The author has submitted the ICMJE Form
for Disclosure of Potential Conflicts of Interest.
Conflicts that the editors consider relevant to
the content of the manuscript have been disclosed.
References
1. Bozzette SA, Joyce G, McCaffrey DF, et al.
Expenditures for the care of HIV-infected
patients in the era of highly active antiretro-
viral therapy. N Engl J Med 2001; 34:817–23.
2. Kitahata MM, Rompaey SE, Dillingham PW,
et al. Primary care delivery is associated with
greater 321 physician experience and im-
proved survival among persons with AIDS.
J Gen Intern Med 2003; 18:95–103.
3. Landon BE, Wilson IB, McInnes K, et al.
Physician specialization and the quality of
care for human immunodeficiency virus
infection. Arch Intern Med 2005; 165:
1133–9.
4. Rackal JM, Tynan AM, Hanford CD, et al.
Provider training and experience for people
living with HIV/AIDS. Cochrane Database
Syst Rev 2011; 6:CD003938.
5. Kitahata MM, Van Rompaey SE, Shields AW.
Physician experience in the care of HIV-
infected persons is associated with earlier adop-
tion of new antiretroviral therapy. J Acquir
Immune Defic Syndr 2000; 24:106–14.
6. Landon BE, Wilson IB, Wenger NS, et al.
Specialty training and specialization among
physicians who treat HIV/AIDS in the Unit-
ed States. J Gen Intern Med 2002; 17:12–22.
7. O’Neill M, Karelas GD, Feller DJ, et al. The
HIV workforce in New York State: does
patient volume correlate with quality? Clin
Infect Dis 2015; 61:1871–7.
8. Gallant JE. What does the generalist need to
know about HIV infection? Adv Chronic
Kidney Dis 2010; 17:5–18.
9. Gallant JE, Adimora AA, Carmichael JK,
et al. Essential components of effective HIV
care: a policy paper of the HIV Medicine
Association of the Infectious Diseases Society
of America and the Ryan White Medical
Providers Coalition. Clin Infect Dis 2011;
53:1043–50.
10. Cohen MS, Chen YQ, McCauley M, et al.
Prevention of HIV-1 infection with antire-
troviral therapy. N Engl J Med 2011; 365:
493–505.
11. Moore RD, Keruly JC, Bartlett JG. Improve-
ment in the health of HIV-infected persons
in care: reducing disparities. Clin Infect Dis
2012; 55:1242–51.
EDITORIAL COMMENTARY • CID 2015:61 (15 December) • 1879
atHINARIPeruAdministrativeAccountonDecember7,2015http://cid.oxfordjournals.org/Downloadedfrom

More Related Content

What's hot

Disorganized Diseases: Are they a Simple Explosion of Random Energy and there...
Disorganized Diseases: Are they a Simple Explosion of Random Energy and there...Disorganized Diseases: Are they a Simple Explosion of Random Energy and there...
Disorganized Diseases: Are they a Simple Explosion of Random Energy and there...
asclepiuspdfs
 
Η συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη Φαρμακοεπιδημιολογία
Η συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη ΦαρμακοεπιδημιολογίαΗ συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη Φαρμακοεπιδημιολογία
Η συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη Φαρμακοεπιδημιολογία
Evangelos Fragkoulis
 
Survillance and notification of communicable disease
Survillance and notification of communicable diseaseSurvillance and notification of communicable disease
Survillance and notification of communicable disease
mubeenButt5
 
Who hiv 2012.29_eng
Who hiv 2012.29_engWho hiv 2012.29_eng
Who hiv 2012.29_engclac.cab
 
English. Dr. Elizabeth Maloney
English. Dr. Elizabeth MaloneyEnglish. Dr. Elizabeth Maloney
Increasing Detection of Intimate Partner Violence and Other Psychosocial Risk...
Increasing Detection of Intimate Partner Violence and Other Psychosocial Risk...Increasing Detection of Intimate Partner Violence and Other Psychosocial Risk...
Increasing Detection of Intimate Partner Violence and Other Psychosocial Risk...
Leonard Davis Institute of Health Economics
 
Where’s the evidence that screening for distress benefits cancer patients?
Where’s the evidence that screening for distress benefits cancer patients?Where’s the evidence that screening for distress benefits cancer patients?
Where’s the evidence that screening for distress benefits cancer patients?
James Coyne
 
Provider Based Patient Engagement - An Essential Strategy for Population Health
Provider Based Patient Engagement - An Essential Strategy for Population HealthProvider Based Patient Engagement - An Essential Strategy for Population Health
Provider Based Patient Engagement - An Essential Strategy for Population Health
Phytel
 
MedicalResearch.com: Medical Research Exclusive Interviews December 31 2014
MedicalResearch.com:  Medical Research Exclusive Interviews December 31 2014MedicalResearch.com:  Medical Research Exclusive Interviews December 31 2014
MedicalResearch.com: Medical Research Exclusive Interviews December 31 2014
Marie Benz MD FAAD
 
Hot Topics Our Genomic Future: Dr Ron Zimmern
Hot Topics Our Genomic Future: Dr Ron ZimmernHot Topics Our Genomic Future: Dr Ron Zimmern
Hot Topics Our Genomic Future: Dr Ron Zimmern
Nesta
 
Think Global, Act Local: Patient and Family Engagement Strategies & Contribut...
Think Global, Act Local: Patient and Family Engagement Strategies & Contribut...Think Global, Act Local: Patient and Family Engagement Strategies & Contribut...
Think Global, Act Local: Patient and Family Engagement Strategies & Contribut...
Canadian Patient Safety Institute
 
Chronic Disease Management Programs - Wellpoint/CareMore
Chronic Disease Management Programs - Wellpoint/CareMoreChronic Disease Management Programs - Wellpoint/CareMore
Chronic Disease Management Programs - Wellpoint/CareMore
Mid-Atlantic Telehealth Resource Center
 
HL Making it Clear
HL Making it Clear HL Making it Clear
Engaging Patients in Antimicrobial Resistance and Stewardship
Engaging Patients in Antimicrobial Resistance and StewardshipEngaging Patients in Antimicrobial Resistance and Stewardship
Engaging Patients in Antimicrobial Resistance and Stewardship
Canadian Patient Safety Institute
 
DOM_Research_Day_Poster 10.26.15
DOM_Research_Day_Poster 10.26.15DOM_Research_Day_Poster 10.26.15
DOM_Research_Day_Poster 10.26.15Hayley Robinett
 
viewpoints_red_gray_v2
viewpoints_red_gray_v2viewpoints_red_gray_v2
viewpoints_red_gray_v2Patty Baraibar
 
Pre and post HIV counseling (VCT)
Pre and post HIV counseling (VCT)Pre and post HIV counseling (VCT)
Pre and post HIV counseling (VCT)
Dr. Rubz
 
Weitzman ECHO COVID-19: Caring for Key Populations
Weitzman ECHO COVID-19: Caring for Key PopulationsWeitzman ECHO COVID-19: Caring for Key Populations
Weitzman ECHO COVID-19: Caring for Key Populations
CHC Connecticut
 

What's hot (20)

Disorganized Diseases: Are they a Simple Explosion of Random Energy and there...
Disorganized Diseases: Are they a Simple Explosion of Random Energy and there...Disorganized Diseases: Are they a Simple Explosion of Random Energy and there...
Disorganized Diseases: Are they a Simple Explosion of Random Energy and there...
 
Η συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη Φαρμακοεπιδημιολογία
Η συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη ΦαρμακοεπιδημιολογίαΗ συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη Φαρμακοεπιδημιολογία
Η συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη Φαρμακοεπιδημιολογία
 
Survillance and notification of communicable disease
Survillance and notification of communicable diseaseSurvillance and notification of communicable disease
Survillance and notification of communicable disease
 
Who hiv 2012.29_eng
Who hiv 2012.29_engWho hiv 2012.29_eng
Who hiv 2012.29_eng
 
English. Dr. Elizabeth Maloney
English. Dr. Elizabeth MaloneyEnglish. Dr. Elizabeth Maloney
English. Dr. Elizabeth Maloney
 
Slp
SlpSlp
Slp
 
Estadistica3
Estadistica3Estadistica3
Estadistica3
 
Increasing Detection of Intimate Partner Violence and Other Psychosocial Risk...
Increasing Detection of Intimate Partner Violence and Other Psychosocial Risk...Increasing Detection of Intimate Partner Violence and Other Psychosocial Risk...
Increasing Detection of Intimate Partner Violence and Other Psychosocial Risk...
 
Where’s the evidence that screening for distress benefits cancer patients?
Where’s the evidence that screening for distress benefits cancer patients?Where’s the evidence that screening for distress benefits cancer patients?
Where’s the evidence that screening for distress benefits cancer patients?
 
Provider Based Patient Engagement - An Essential Strategy for Population Health
Provider Based Patient Engagement - An Essential Strategy for Population HealthProvider Based Patient Engagement - An Essential Strategy for Population Health
Provider Based Patient Engagement - An Essential Strategy for Population Health
 
MedicalResearch.com: Medical Research Exclusive Interviews December 31 2014
MedicalResearch.com:  Medical Research Exclusive Interviews December 31 2014MedicalResearch.com:  Medical Research Exclusive Interviews December 31 2014
MedicalResearch.com: Medical Research Exclusive Interviews December 31 2014
 
Hot Topics Our Genomic Future: Dr Ron Zimmern
Hot Topics Our Genomic Future: Dr Ron ZimmernHot Topics Our Genomic Future: Dr Ron Zimmern
Hot Topics Our Genomic Future: Dr Ron Zimmern
 
Think Global, Act Local: Patient and Family Engagement Strategies & Contribut...
Think Global, Act Local: Patient and Family Engagement Strategies & Contribut...Think Global, Act Local: Patient and Family Engagement Strategies & Contribut...
Think Global, Act Local: Patient and Family Engagement Strategies & Contribut...
 
Chronic Disease Management Programs - Wellpoint/CareMore
Chronic Disease Management Programs - Wellpoint/CareMoreChronic Disease Management Programs - Wellpoint/CareMore
Chronic Disease Management Programs - Wellpoint/CareMore
 
HL Making it Clear
HL Making it Clear HL Making it Clear
HL Making it Clear
 
Engaging Patients in Antimicrobial Resistance and Stewardship
Engaging Patients in Antimicrobial Resistance and StewardshipEngaging Patients in Antimicrobial Resistance and Stewardship
Engaging Patients in Antimicrobial Resistance and Stewardship
 
DOM_Research_Day_Poster 10.26.15
DOM_Research_Day_Poster 10.26.15DOM_Research_Day_Poster 10.26.15
DOM_Research_Day_Poster 10.26.15
 
viewpoints_red_gray_v2
viewpoints_red_gray_v2viewpoints_red_gray_v2
viewpoints_red_gray_v2
 
Pre and post HIV counseling (VCT)
Pre and post HIV counseling (VCT)Pre and post HIV counseling (VCT)
Pre and post HIV counseling (VCT)
 
Weitzman ECHO COVID-19: Caring for Key Populations
Weitzman ECHO COVID-19: Caring for Key PopulationsWeitzman ECHO COVID-19: Caring for Key Populations
Weitzman ECHO COVID-19: Caring for Key Populations
 

Viewers also liked

Tâche 2: Comment s'y prendre
Tâche 2: Comment s'y prendreTâche 2: Comment s'y prendre
Tâche 2: Comment s'y prendrepatriinsua
 
Presentación
PresentaciónPresentación
Presentación
cholan95
 
Sampailah saat si bungsu mengutarakan maksudnya untuk kembali pulang
Sampailah saat si bungsu mengutarakan maksudnya untuk kembali pulangSampailah saat si bungsu mengutarakan maksudnya untuk kembali pulang
Sampailah saat si bungsu mengutarakan maksudnya untuk kembali pulang
Evan Ehsanudin
 
lectura 1, ¿EN QUÉ DIFEREN LOS ÓXIDOS METÁLICOS DE LOS NO METÁLICOS?, mapa me...
lectura 1, ¿EN QUÉ DIFEREN LOS ÓXIDOS METÁLICOS DE LOS NO METÁLICOS?, mapa me...lectura 1, ¿EN QUÉ DIFEREN LOS ÓXIDOS METÁLICOS DE LOS NO METÁLICOS?, mapa me...
lectura 1, ¿EN QUÉ DIFEREN LOS ÓXIDOS METÁLICOS DE LOS NO METÁLICOS?, mapa me...M Joselin Sanchez Hernandez
 
The 50 states story ci class
The 50 states story ci classThe 50 states story ci class
The 50 states story ci class
jones909
 
America in black and white
America in black and whiteAmerica in black and white
America in black and white
Nguyễn Đăng
 
Feminists Editing Wikipedia
Feminists Editing WikipediaFeminists Editing Wikipedia
Feminists Editing Wikipedia
Jessie Daniels
 
Create A Greeting Card
Create A Greeting CardCreate A Greeting Card
Create A Greeting CardZay Guwop
 
Parshiot b’har & b’hukotai dayenu!
Parshiot b’har & b’hukotai dayenu! Parshiot b’har & b’hukotai dayenu!
Parshiot b’har & b’hukotai dayenu!
Rabbi Ari Kahn
 
Fortalezas y debilidades
Fortalezas y debilidadesFortalezas y debilidades
Fortalezas y debilidades
rocior4
 
Ci 350 assure method monday dakota weant
Ci 350 assure method monday dakota weantCi 350 assure method monday dakota weant
Ci 350 assure method monday dakota weant
Herdheaven
 
Métodos básicos
Métodos básicosMétodos básicos
Métodos básicos
rocior4
 
El español y las lenguas amerindias en hispanoamérica.
El español y las lenguas amerindias en hispanoamérica.El español y las lenguas amerindias en hispanoamérica.
El español y las lenguas amerindias en hispanoamérica.
Escritura Creativa
 
SDN Project PPT
SDN Project PPTSDN Project PPT
SDN Project PPT
Matthew Chang
 
Palacio de Cristal
Palacio de CristalPalacio de Cristal
Palacio de Cristal
benedetti6
 
Variación lingüística en español
Variación lingüística en españolVariación lingüística en español
Variación lingüística en español
Escritura Creativa
 

Viewers also liked (18)

Tâche 2: Comment s'y prendre
Tâche 2: Comment s'y prendreTâche 2: Comment s'y prendre
Tâche 2: Comment s'y prendre
 
Presentación
PresentaciónPresentación
Presentación
 
Sampailah saat si bungsu mengutarakan maksudnya untuk kembali pulang
Sampailah saat si bungsu mengutarakan maksudnya untuk kembali pulangSampailah saat si bungsu mengutarakan maksudnya untuk kembali pulang
Sampailah saat si bungsu mengutarakan maksudnya untuk kembali pulang
 
Sudarsang electrical designer
Sudarsang electrical designerSudarsang electrical designer
Sudarsang electrical designer
 
lectura 1, ¿EN QUÉ DIFEREN LOS ÓXIDOS METÁLICOS DE LOS NO METÁLICOS?, mapa me...
lectura 1, ¿EN QUÉ DIFEREN LOS ÓXIDOS METÁLICOS DE LOS NO METÁLICOS?, mapa me...lectura 1, ¿EN QUÉ DIFEREN LOS ÓXIDOS METÁLICOS DE LOS NO METÁLICOS?, mapa me...
lectura 1, ¿EN QUÉ DIFEREN LOS ÓXIDOS METÁLICOS DE LOS NO METÁLICOS?, mapa me...
 
The 50 states story ci class
The 50 states story ci classThe 50 states story ci class
The 50 states story ci class
 
America in black and white
America in black and whiteAmerica in black and white
America in black and white
 
Feminists Editing Wikipedia
Feminists Editing WikipediaFeminists Editing Wikipedia
Feminists Editing Wikipedia
 
Create A Greeting Card
Create A Greeting CardCreate A Greeting Card
Create A Greeting Card
 
Parshiot b’har & b’hukotai dayenu!
Parshiot b’har & b’hukotai dayenu! Parshiot b’har & b’hukotai dayenu!
Parshiot b’har & b’hukotai dayenu!
 
Fortalezas y debilidades
Fortalezas y debilidadesFortalezas y debilidades
Fortalezas y debilidades
 
Ci 350 assure method monday dakota weant
Ci 350 assure method monday dakota weantCi 350 assure method monday dakota weant
Ci 350 assure method monday dakota weant
 
BEUTOUR-PP
BEUTOUR-PPBEUTOUR-PP
BEUTOUR-PP
 
Métodos básicos
Métodos básicosMétodos básicos
Métodos básicos
 
El español y las lenguas amerindias en hispanoamérica.
El español y las lenguas amerindias en hispanoamérica.El español y las lenguas amerindias en hispanoamérica.
El español y las lenguas amerindias en hispanoamérica.
 
SDN Project PPT
SDN Project PPTSDN Project PPT
SDN Project PPT
 
Palacio de Cristal
Palacio de CristalPalacio de Cristal
Palacio de Cristal
 
Variación lingüística en español
Variación lingüística en españolVariación lingüística en español
Variación lingüística en español
 

Similar to Clin infect dis. 2015-gallant-1878-9

Clin infect dis. 2015-o'neill-1871-7
Clin infect dis. 2015-o'neill-1871-7Clin infect dis. 2015-o'neill-1871-7
Clin infect dis. 2015-o'neill-1871-7
Alex Castañeda-Sabogal
 
Global Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USAGlobal Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™
 
Read the article on the following 2 pages, Fighting HIV a Commu.docx
Read the article on the following 2 pages, Fighting HIV a Commu.docxRead the article on the following 2 pages, Fighting HIV a Commu.docx
Read the article on the following 2 pages, Fighting HIV a Commu.docx
catheryncouper
 
PROVIDERS CHALLENGE FOR TREATING INFECTIOUS3PROVIDERS CHALLENGE.docx
PROVIDERS CHALLENGE FOR TREATING INFECTIOUS3PROVIDERS CHALLENGE.docxPROVIDERS CHALLENGE FOR TREATING INFECTIOUS3PROVIDERS CHALLENGE.docx
PROVIDERS CHALLENGE FOR TREATING INFECTIOUS3PROVIDERS CHALLENGE.docx
woodruffeloisa
 
Meghaan Walsh HJS Poster[1]
Meghaan Walsh HJS Poster[1]Meghaan Walsh HJS Poster[1]
Meghaan Walsh HJS Poster[1]Mary Beth Levin
 
10 top patient safety issues for 2016 by Dr.Mahboob ali khan Phd
10 top patient safety issues for 2016 by Dr.Mahboob ali khan Phd 10 top patient safety issues for 2016 by Dr.Mahboob ali khan Phd
10 top patient safety issues for 2016 by Dr.Mahboob ali khan Phd
Healthcare consultant
 
Exploring Knowledge, Attitudes and Practices of ICU Health Workers Regarding ...
Exploring Knowledge, Attitudes and Practices of ICU Health Workers Regarding ...Exploring Knowledge, Attitudes and Practices of ICU Health Workers Regarding ...
Exploring Knowledge, Attitudes and Practices of ICU Health Workers Regarding ...
QUESTJOURNAL
 
Reducing HIV Stigma Among Nursing Students.docx
Reducing HIV Stigma Among Nursing Students.docxReducing HIV Stigma Among Nursing Students.docx
Reducing HIV Stigma Among Nursing Students.docx
write22
 
A new options for hiv prevention slides.2013
A new options for hiv prevention slides.2013A new options for hiv prevention slides.2013
A new options for hiv prevention slides.2013Hivlife Info
 
2014 Report: Medicines in Development for HIV/AIDS
2014 Report: Medicines in Development for HIV/AIDS2014 Report: Medicines in Development for HIV/AIDS
2014 Report: Medicines in Development for HIV/AIDS
PhRMA
 
2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docx
2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docx2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docx
2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docx
vickeryr87
 
San Diego Primary Care Providers' Attitudes to HIV and HIV Testing
San Diego Primary Care Providers' Attitudes to HIV and HIV TestingSan Diego Primary Care Providers' Attitudes to HIV and HIV Testing
San Diego Primary Care Providers' Attitudes to HIV and HIV Testing
UC San Diego AntiViral Research Center
 
international-archives-of-nursing-and-health-care-ianhc-10-195.pdf
international-archives-of-nursing-and-health-care-ianhc-10-195.pdfinternational-archives-of-nursing-and-health-care-ianhc-10-195.pdf
international-archives-of-nursing-and-health-care-ianhc-10-195.pdf
DerejeBayissa2
 
Central Line-associated Bloodstream Infections.Walden Universi
Central Line-associated Bloodstream Infections.Walden UniversiCentral Line-associated Bloodstream Infections.Walden Universi
Central Line-associated Bloodstream Infections.Walden Universi
MaximaSheffield592
 
Piis074937970300120 x
Piis074937970300120 xPiis074937970300120 x
Piis074937970300120 x
Luis Carlos Murillo Valencia
 
Knowledge-and-Practice-of-Hepatitis-B-Prevention-among-Health-Care-Workers-in...
Knowledge-and-Practice-of-Hepatitis-B-Prevention-among-Health-Care-Workers-in...Knowledge-and-Practice-of-Hepatitis-B-Prevention-among-Health-Care-Workers-in...
Knowledge-and-Practice-of-Hepatitis-B-Prevention-among-Health-Care-Workers-in...
FrancisOpwonya1
 
People With HIV Whose Viral Loads Are Undetectable Present.pdf
People With HIV Whose Viral Loads Are Undetectable Present.pdfPeople With HIV Whose Viral Loads Are Undetectable Present.pdf
People With HIV Whose Viral Loads Are Undetectable Present.pdf
The Lifesciences Magazine
 

Similar to Clin infect dis. 2015-gallant-1878-9 (20)

Clin infect dis. 2015-o'neill-1871-7
Clin infect dis. 2015-o'neill-1871-7Clin infect dis. 2015-o'neill-1871-7
Clin infect dis. 2015-o'neill-1871-7
 
Article
ArticleArticle
Article
 
Global Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USAGlobal Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USA
 
Read the article on the following 2 pages, Fighting HIV a Commu.docx
Read the article on the following 2 pages, Fighting HIV a Commu.docxRead the article on the following 2 pages, Fighting HIV a Commu.docx
Read the article on the following 2 pages, Fighting HIV a Commu.docx
 
PROVIDERS CHALLENGE FOR TREATING INFECTIOUS3PROVIDERS CHALLENGE.docx
PROVIDERS CHALLENGE FOR TREATING INFECTIOUS3PROVIDERS CHALLENGE.docxPROVIDERS CHALLENGE FOR TREATING INFECTIOUS3PROVIDERS CHALLENGE.docx
PROVIDERS CHALLENGE FOR TREATING INFECTIOUS3PROVIDERS CHALLENGE.docx
 
Meghaan Walsh HJS Poster[1]
Meghaan Walsh HJS Poster[1]Meghaan Walsh HJS Poster[1]
Meghaan Walsh HJS Poster[1]
 
10 top patient safety issues for 2016 by Dr.Mahboob ali khan Phd
10 top patient safety issues for 2016 by Dr.Mahboob ali khan Phd 10 top patient safety issues for 2016 by Dr.Mahboob ali khan Phd
10 top patient safety issues for 2016 by Dr.Mahboob ali khan Phd
 
Exploring Knowledge, Attitudes and Practices of ICU Health Workers Regarding ...
Exploring Knowledge, Attitudes and Practices of ICU Health Workers Regarding ...Exploring Knowledge, Attitudes and Practices of ICU Health Workers Regarding ...
Exploring Knowledge, Attitudes and Practices of ICU Health Workers Regarding ...
 
Reducing HIV Stigma Among Nursing Students.docx
Reducing HIV Stigma Among Nursing Students.docxReducing HIV Stigma Among Nursing Students.docx
Reducing HIV Stigma Among Nursing Students.docx
 
A new options for hiv prevention slides.2013
A new options for hiv prevention slides.2013A new options for hiv prevention slides.2013
A new options for hiv prevention slides.2013
 
2014 Report: Medicines in Development for HIV/AIDS
2014 Report: Medicines in Development for HIV/AIDS2014 Report: Medicines in Development for HIV/AIDS
2014 Report: Medicines in Development for HIV/AIDS
 
2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docx
2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docx2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docx
2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docx
 
San Diego Primary Care Providers' Attitudes to HIV and HIV Testing
San Diego Primary Care Providers' Attitudes to HIV and HIV TestingSan Diego Primary Care Providers' Attitudes to HIV and HIV Testing
San Diego Primary Care Providers' Attitudes to HIV and HIV Testing
 
international-archives-of-nursing-and-health-care-ianhc-10-195.pdf
international-archives-of-nursing-and-health-care-ianhc-10-195.pdfinternational-archives-of-nursing-and-health-care-ianhc-10-195.pdf
international-archives-of-nursing-and-health-care-ianhc-10-195.pdf
 
Central Line-associated Bloodstream Infections.Walden Universi
Central Line-associated Bloodstream Infections.Walden UniversiCentral Line-associated Bloodstream Infections.Walden Universi
Central Line-associated Bloodstream Infections.Walden Universi
 
Piis074937970300120 x
Piis074937970300120 xPiis074937970300120 x
Piis074937970300120 x
 
HATS_Medwiser_A
HATS_Medwiser_AHATS_Medwiser_A
HATS_Medwiser_A
 
Knowledge-and-Practice-of-Hepatitis-B-Prevention-among-Health-Care-Workers-in...
Knowledge-and-Practice-of-Hepatitis-B-Prevention-among-Health-Care-Workers-in...Knowledge-and-Practice-of-Hepatitis-B-Prevention-among-Health-Care-Workers-in...
Knowledge-and-Practice-of-Hepatitis-B-Prevention-among-Health-Care-Workers-in...
 
People With HIV Whose Viral Loads Are Undetectable Present.pdf
People With HIV Whose Viral Loads Are Undetectable Present.pdfPeople With HIV Whose Viral Loads Are Undetectable Present.pdf
People With HIV Whose Viral Loads Are Undetectable Present.pdf
 
HIV Nursing
HIV NursingHIV Nursing
HIV Nursing
 

More from Alex Castañeda-Sabogal

Ngc sepsis
Ngc sepsisNgc sepsis
Manual redes sociales omc
Manual redes sociales omcManual redes sociales omc
Manual redes sociales omc
Alex Castañeda-Sabogal
 
Tb XDR in South Africa
Tb XDR in South AfricaTb XDR in South Africa
Tb XDR in South Africa
Alex Castañeda-Sabogal
 
ACTG 5273
ACTG 5273ACTG 5273
Shortened hep c combo passes real world
Shortened hep c combo passes real worldShortened hep c combo passes real world
Shortened hep c combo passes real world
Alex Castañeda-Sabogal
 
Truvada kaletra o raltegravir pr ep
Truvada kaletra o raltegravir pr epTruvada kaletra o raltegravir pr ep
Truvada kaletra o raltegravir pr ep
Alex Castañeda-Sabogal
 
Truvada kaletra o maraviroc PrEp
Truvada kaletra o maraviroc PrEpTruvada kaletra o maraviroc PrEp
Truvada kaletra o maraviroc PrEp
Alex Castañeda-Sabogal
 
Truvada EFV en VIH TB
Truvada EFV en VIH TBTruvada EFV en VIH TB
Truvada EFV en VIH TB
Alex Castañeda-Sabogal
 
Nueva definicion de Sepsis 2016
Nueva definicion de Sepsis 2016Nueva definicion de Sepsis 2016
Nueva definicion de Sepsis 2016
Alex Castañeda-Sabogal
 
Atb y resistencia en neumonias virales
Atb y resistencia en neumonias viralesAtb y resistencia en neumonias virales
Atb y resistencia en neumonias virales
Alex Castañeda-Sabogal
 
Clinical perspectives on_echinocandin_resistance
Clinical perspectives on_echinocandin_resistanceClinical perspectives on_echinocandin_resistance
Clinical perspectives on_echinocandin_resistance
Alex Castañeda-Sabogal
 
Antibiotic de escalation_in_the_icu___how_is_it.
Antibiotic de escalation_in_the_icu___how_is_it.Antibiotic de escalation_in_the_icu___how_is_it.
Antibiotic de escalation_in_the_icu___how_is_it.
Alex Castañeda-Sabogal
 
The future of_antivirals___broad_spectrum.15
The future of_antivirals___broad_spectrum.15The future of_antivirals___broad_spectrum.15
The future of_antivirals___broad_spectrum.15
Alex Castañeda-Sabogal
 
Etiologia de la celulitis
Etiologia de la celulitisEtiologia de la celulitis
Etiologia de la celulitis
Alex Castañeda-Sabogal
 
Cd8 y cmv en vih
Cd8 y cmv en vihCd8 y cmv en vih
Cd8 y cmv en vih
Alex Castañeda-Sabogal
 
Etiologia de la celulitis y Predicción clínica de la enfermedad Estreptocócic...
Etiologia de la celulitis y Predicción clínica de la enfermedad Estreptocócic...Etiologia de la celulitis y Predicción clínica de la enfermedad Estreptocócic...
Etiologia de la celulitis y Predicción clínica de la enfermedad Estreptocócic...
Alex Castañeda-Sabogal
 
CD8 y CMV en VIH
CD8 y CMV en VIHCD8 y CMV en VIH
CD8 y CMV en VIH
Alex Castañeda-Sabogal
 
Clin infect dis. 2016-cao-250-7
Clin infect dis. 2016-cao-250-7Clin infect dis. 2016-cao-250-7
Clin infect dis. 2016-cao-250-7
Alex Castañeda-Sabogal
 
Tto tbc nejm
Tto tbc nejmTto tbc nejm
Tuberculina vs IGRA
Tuberculina vs IGRATuberculina vs IGRA
Tuberculina vs IGRA
Alex Castañeda-Sabogal
 

More from Alex Castañeda-Sabogal (20)

Ngc sepsis
Ngc sepsisNgc sepsis
Ngc sepsis
 
Manual redes sociales omc
Manual redes sociales omcManual redes sociales omc
Manual redes sociales omc
 
Tb XDR in South Africa
Tb XDR in South AfricaTb XDR in South Africa
Tb XDR in South Africa
 
ACTG 5273
ACTG 5273ACTG 5273
ACTG 5273
 
Shortened hep c combo passes real world
Shortened hep c combo passes real worldShortened hep c combo passes real world
Shortened hep c combo passes real world
 
Truvada kaletra o raltegravir pr ep
Truvada kaletra o raltegravir pr epTruvada kaletra o raltegravir pr ep
Truvada kaletra o raltegravir pr ep
 
Truvada kaletra o maraviroc PrEp
Truvada kaletra o maraviroc PrEpTruvada kaletra o maraviroc PrEp
Truvada kaletra o maraviroc PrEp
 
Truvada EFV en VIH TB
Truvada EFV en VIH TBTruvada EFV en VIH TB
Truvada EFV en VIH TB
 
Nueva definicion de Sepsis 2016
Nueva definicion de Sepsis 2016Nueva definicion de Sepsis 2016
Nueva definicion de Sepsis 2016
 
Atb y resistencia en neumonias virales
Atb y resistencia en neumonias viralesAtb y resistencia en neumonias virales
Atb y resistencia en neumonias virales
 
Clinical perspectives on_echinocandin_resistance
Clinical perspectives on_echinocandin_resistanceClinical perspectives on_echinocandin_resistance
Clinical perspectives on_echinocandin_resistance
 
Antibiotic de escalation_in_the_icu___how_is_it.
Antibiotic de escalation_in_the_icu___how_is_it.Antibiotic de escalation_in_the_icu___how_is_it.
Antibiotic de escalation_in_the_icu___how_is_it.
 
The future of_antivirals___broad_spectrum.15
The future of_antivirals___broad_spectrum.15The future of_antivirals___broad_spectrum.15
The future of_antivirals___broad_spectrum.15
 
Etiologia de la celulitis
Etiologia de la celulitisEtiologia de la celulitis
Etiologia de la celulitis
 
Cd8 y cmv en vih
Cd8 y cmv en vihCd8 y cmv en vih
Cd8 y cmv en vih
 
Etiologia de la celulitis y Predicción clínica de la enfermedad Estreptocócic...
Etiologia de la celulitis y Predicción clínica de la enfermedad Estreptocócic...Etiologia de la celulitis y Predicción clínica de la enfermedad Estreptocócic...
Etiologia de la celulitis y Predicción clínica de la enfermedad Estreptocócic...
 
CD8 y CMV en VIH
CD8 y CMV en VIHCD8 y CMV en VIH
CD8 y CMV en VIH
 
Clin infect dis. 2016-cao-250-7
Clin infect dis. 2016-cao-250-7Clin infect dis. 2016-cao-250-7
Clin infect dis. 2016-cao-250-7
 
Tto tbc nejm
Tto tbc nejmTto tbc nejm
Tto tbc nejm
 
Tuberculina vs IGRA
Tuberculina vs IGRATuberculina vs IGRA
Tuberculina vs IGRA
 

Recently uploaded

heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 

Recently uploaded (20)

heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 

Clin infect dis. 2015-gallant-1878-9

  • 1. E D I T O R I A L C O M M E N T A R Y HIV Infection: Still a Disease for Experts Joel E. Gallant Southwest CARE Center, Santa Fe, New Mexico (See the HIV/AIDS Major Article by O’Neill et al on pages 1871–7.) Keywords. HIV; AIDS; expertise; primary care. For decades, human immunodeficiency virus (HIV) infection was viewed as a dis- ease that should be managed by experts. This was based on the multitude of po- tential complications, the complexity of antiretroviral drug regimens and their toxicities, the need for understanding of drug resistance, and the numerous interactions between many HIV drugs and other commonly used medications. This assumption was supported by data showing improved outcomes, prolonged survival, and lower costs when HIV- infected patients were managed by ex- perts [1–6]. The term “HIV expert” was never well defined, because there is no specialty boardforHIVmedicine. HIVexpertshave included infectious disease specialists, family practitioners, internists, pediatri- cians, as well as nonphysician providers such as nurse practitioners and physician assistants. The HIV Medicine Associa- tion and the American Academy of HIV Medicine (AAHIVM) have attempt- ed to define HIV expertise using a combi- nation of provider experience (patient volume) and HIV-specific continuing medical education (CME). The AAHIVM also requires passing of an open-book exam for certification as a “practicing HIV specialist.” In recent years, the need for HIV ex- pertise has been questioned. It has been argued that the earlier studies don’t apply in an era when we can treat HIV in- fection with simple, well-tolerated regi- mens, including several single tablet combinations. Virologic failure is now less common, making it less important to have a thorough understanding of drug resistance. Many of the recommended treatment regimens have few drug inter- actions. At the same time, the Affordable Care Act (ACA) makes it possible for most HIV-infected patients to be covered by private insurance or Medicaid, lessen- ing the need for reliance on HIV clinics funded by the Ryan White HIV/AIDS Program (RWHAP). Those on Medicaid will increasingly be treated in Federally Qualified Health Centers (FQHCs), which may not always have providers with HIV expertise. These factors have encouraged many to talk about HIV infection as a “primary care disease.” The study by O’Neill and colleagues in this issue of Clinical Infectious Diseases [7] suggests that it is premature to reclas- sify HIV infection as a disease that can be managed by generalists. The authors compared outcomes of HIV-infected pa- tients in New York state who were treated by low volume providers (LVPs), defined as clinicians prescribing antiretroviral therapy (ART) to less than 20 patients, with those managed by more experienced providers, caring for at least 20 patients. They found 368 providers who confirmed that they were providing HIV care for less than 20 patients (average 4.3). Of those, 84 submitted the medical records of 320 patients for review. Those records were compared with records from experienced providers, randomly sampled from 186 HIVprograms.Performancemeasureswere based on DHHS (Department of Health and Human Services) guidelines in place at the time. Patients of LVPs were less likely to be virologically suppressed and had lower scores for all quality of care indica- tors, including frequency of clinic visits, viral load and CD4 count monitoring, and mental health and syphilis screening. The authors point out that there may be a selection bias affecting their findings in that those providers who responded to the survey and agreed to provide patient re- cords may have been more confident of the quality of their care than those who did not, potentiallyhidingevengreaterdiscrepancies between LVPs and experienced providers. It has been argued that 20 patients may be an unreasonable standard for rural areas. However, in this study, although patients living outside the New York met- ropolitan area were more likely to be cared for by LVPs, nearly three-quarters of the LVPs were practicing in the metro- politan area, where there is no shortage of HIV experts. Received 6 August 2015; accepted 11 August 2015; elec- tronically published 30 September 2015. Correspondence: Joel E. Gallant, MD, MPH, Southwest CARE Center, 649 Harkle Rd, Ste E, Santa Fe, New Mexico (jgallant@southwestcare.org). Clinical Infectious Diseases® 2015;61(12):1878–9 © The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals. permissions@oup.com. DOI: 10.1093/cid/civ724 1878 • CID 2015:61 (15 December) • EDITORIAL COMMENTARY atHINARIPeruAdministrativeAccountonDecember7,2015http://cid.oxfordjournals.org/Downloadedfrom
  • 2. This is the first study to assess the effect of provider expertise on quality of care in a large state or public health jurisdiction, and it is also the most contemporary. The data collected were based on antiretrovi- ral therapy (ART) prescribed in 2009. Al- though significant improvements have occurred in the last 6 years, 2009 is still part of the “modern ART era,” character- ized by simpler, better tolerated, and less toxic treatments. Why the difference? The obvious an- swer is simply greater experience and knowledge among providers who treat more HIV-infected patients. However, other factors may also play a role. Provid- ers caring for more HIV-infected patients may be working in environments with support services, including behavioral healthservices,substanceabusetreatment, case management, and adherence sup- port: the kind of “wrap-around” services typically found in Ryan White clinics. They may also have more access to on-site HIV education and expert supervision. Our healthcare environment is rapidly changing. HIV-infected patients are in- creasingly likely to be managed by gener- alists in FQHCs or primary care practices rather than in Ryan White clinics. The number of clinicians choosing HIV care as a profession is shrinking. In such a cli- mate, how do we maintain high-quality HIV care, which is critical not only for the health of patients but also for decreas- ing HIV transmission and controlling the epidemic? In urban and suburban areas, clinics must recognize the importance of HIV expertise, either by hiring experts or by supporting HIV training by some of their providers. This may include atten- dance at HIV courses or preceptorships in existing HIV clinics as well ongoing HIV-specific CME. Co-management by primary care providers and HIV experts is underutilized, and is especially impor- tant in rural areas where there may be no experts. This can be achieved either by infrequent visits with an expert, regular communication between the generalist or the expert, or through telemedicine, which must be adequately compensated by third party payers [8]. Teleconferencing pro- grams, such as Project ECHO, can be used to build expertise among primary care pro- viders and budding HIV experts through regular lectures and case presentations. The findings from the O’Neill study emphasize the critical need for im- plementation of HIV-specific quality measures—most importantly viral load suppression—by public and private in- surers. They also make a strong argument for continued funding for the RWHAP. Although some have argued that the RWHAP is unnecessary after passage of the ACA, Ryan White clinics have be- come centers of excellence for HIV care and have provided training for HIV pro- viders over several decades. They offer support services that may not exist in other healthcare settings and that have been critical in keeping HIV-infected pa- tients retained in care and virologically suppressed: the key components of treat- ment-as prevention [9–11]. Attempts have also been made to solidify and for- malize the definition of an HIV expert, including the proposal for a board exam that would provide “focused practice rec- ognition” to providers from a variety of disciplines. However, for such recognition and certification to have meaning, private and government insurers would have to recognize the value of HIV expertise, making it an indicator of quality care. Diagnosing HIV infection, enrolling and retaining patients in care, and sup- pressing their viral loads on ART are fundamental to controlling the HIV epi- demic. HIV care may be easier than it used to be, but it is still complex. This is no time to relax our standards and turn HIV care over to generalists. HIV in- fection should still be managed—or co- managed—by experts. Note Potential conflict of interest. The author is the Immediate Past Chair, HIV Medicine Association. The author has submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. References 1. Bozzette SA, Joyce G, McCaffrey DF, et al. Expenditures for the care of HIV-infected patients in the era of highly active antiretro- viral therapy. N Engl J Med 2001; 34:817–23. 2. Kitahata MM, Rompaey SE, Dillingham PW, et al. Primary care delivery is associated with greater 321 physician experience and im- proved survival among persons with AIDS. J Gen Intern Med 2003; 18:95–103. 3. Landon BE, Wilson IB, McInnes K, et al. Physician specialization and the quality of care for human immunodeficiency virus infection. Arch Intern Med 2005; 165: 1133–9. 4. Rackal JM, Tynan AM, Hanford CD, et al. Provider training and experience for people living with HIV/AIDS. Cochrane Database Syst Rev 2011; 6:CD003938. 5. Kitahata MM, Van Rompaey SE, Shields AW. Physician experience in the care of HIV- infected persons is associated with earlier adop- tion of new antiretroviral therapy. J Acquir Immune Defic Syndr 2000; 24:106–14. 6. Landon BE, Wilson IB, Wenger NS, et al. Specialty training and specialization among physicians who treat HIV/AIDS in the Unit- ed States. J Gen Intern Med 2002; 17:12–22. 7. O’Neill M, Karelas GD, Feller DJ, et al. The HIV workforce in New York State: does patient volume correlate with quality? Clin Infect Dis 2015; 61:1871–7. 8. Gallant JE. What does the generalist need to know about HIV infection? Adv Chronic Kidney Dis 2010; 17:5–18. 9. Gallant JE, Adimora AA, Carmichael JK, et al. Essential components of effective HIV care: a policy paper of the HIV Medicine Association of the Infectious Diseases Society of America and the Ryan White Medical Providers Coalition. Clin Infect Dis 2011; 53:1043–50. 10. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with antire- troviral therapy. N Engl J Med 2011; 365: 493–505. 11. Moore RD, Keruly JC, Bartlett JG. Improve- ment in the health of HIV-infected persons in care: reducing disparities. Clin Infect Dis 2012; 55:1242–51. EDITORIAL COMMENTARY • CID 2015:61 (15 December) • 1879 atHINARIPeruAdministrativeAccountonDecember7,2015http://cid.oxfordjournals.org/Downloadedfrom